Floatz logo

CITALOPRAM

Alcoholism

University of Texas Southwestern Medical CenterSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Alcoholism cohort.

Asset / SponsorPhaseRating
FLUOXETINE
New York State Psychiatric Institute
Phase 4BB
Wellbutrin
New York State Psychiatric Institute
Phase 4BB
Sertraline
University of Texas Southwestern Medical Center
Phase 3BB
Risperdal
Dartmouth-Hitchcock Medical Center
Phase 2B
Glycine
Yale University
Phase 2B

View all 12 →

Same molecule, other indications

CITALOPRAM is also rated in:

Bipolar I DisorderDormant
BBB
Indicative ·
77 / 100
View asset →
bipolar disorderDormant
BBB
Indicative ·
74 / 100
View asset →
depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →